Pages that link to "Q24617949"
Jump to navigation
Jump to search
The following pages link to The genomic complexity of primary human prostate cancer (Q24617949):
Displaying 50 items.
- GROM-RD: resolving genomic biases to improve read depth detection of copy number variants (Q21128696) (← links)
- Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy (Q21131727) (← links)
- Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer (Q21184064) (← links)
- Integrative annotation of variants from 1092 humans: application to cancer genomics (Q22065599) (← links)
- Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase (Q24336527) (← links)
- SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer (Q24339492) (← links)
- NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes (Q24596715) (← links)
- Melanoma genome sequencing reveals frequent PREX2 mutations (Q24610463) (← links)
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer (Q24616117) (← links)
- Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genes (Q24619351) (← links)
- Mutational processes molding the genomes of 21 breast cancers (Q24620915) (← links)
- Genome sequencing identifies a basis for everolimus sensitivity (Q24631915) (← links)
- The genomic and transcriptomic landscape of a HeLa cell line (Q24632989) (← links)
- Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications (Q26747274) (← links)
- Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas (Q26751724) (← links)
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression (Q26766149) (← links)
- The structure and function of NKAIN2-a candidate tumor suppressor (Q26771844) (← links)
- Molecular Process Producing Oncogene Fusion in Lung Cancer Cells by Illegitimate Repair of DNA Double-Strand Breaks (Q26781994) (← links)
- The path to routine use of genomic biomarkers in the cancer clinic (Q26782733) (← links)
- Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications (Q26797063) (← links)
- Molecular landscape of prostate cancer: implications for current clinical trials (Q26799585) (← links)
- Mutational signatures: the patterns of somatic mutations hidden in cancer genomes (Q26850125) (← links)
- Recurrent rearrangements in prostate cancer: causes and therapeutic potential (Q26851525) (← links)
- The mutational landscape of prostate cancer (Q26851631) (← links)
- Genomic sequencing in cancer (Q26853507) (← links)
- Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer (Q26858922) (← links)
- Systems biology of cisplatin resistance: past, present and future (Q26863585) (← links)
- Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges (Q26864808) (← links)
- How many molecular subtypes? Implications of the unique tumor principle in personalized medicine (Q26992045) (← links)
- Genome sequencing and cancer (Q26998499) (← links)
- Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies (Q27007065) (← links)
- Quo vadis: advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies (Q27011642) (← links)
- Emerging patterns of somatic mutations in cancer (Q27014126) (← links)
- Evolution of the cancer genome (Q27020991) (← links)
- Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression (Q27022288) (← links)
- Current evidence linking polyunsaturated Fatty acids with cancer risk and progression (Q27022573) (← links)
- Pediatric solid tumor genomics and developmental pliancy (Q27023560) (← links)
- Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine (Q27024626) (← links)
- Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution. (Q27690285) (← links)
- Integrative clinical genomics of advanced prostate cancer (Q27853170) (← links)
- Noncanonical views of homology-directed DNA repair (Q28080032) (← links)
- Comprehensive genomic characterization of squamous cell lung cancers (Q28274701) (← links)
- Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing (Q28275103) (← links)
- Inactivating CUX1 mutations promote tumorigenesis (Q28303563) (← links)
- Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas (Q28305680) (← links)
- Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics (Q28394818) (← links)
- SRC kinase regulation in progressively invasive cancer (Q28484914) (← links)
- Guanine holes are prominent targets for mutation in cancer and inherited disease (Q28533852) (← links)
- Chd5 requires PHD-mediated histone 3 binding for tumor suppression (Q28593132) (← links)
- The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer (Q28687241) (← links)